{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A Phase 1b\/2 Dose-Escalation and Cohort-Expansion Study to Determine the Safety and Efficacy of BGB-11417 as Monotherapy, in Combination With Dexamethasone, Dexamethasone\/Carfilzomib, Dexamethasone\/Daratumumab, and Dexamethasone\/Pomalidomide in Patients With Relapsed\/Refractory Multiple Myeloma and t(11;14)","item":"https:\/\/www.regionalcancercare.org\/trials\/a-phase-1b-2-dose-escalation-and-cohort-expansion-study-to-determine-the-safety-and-efficacy-of-bgb-11417-as-monotherapy-in-combination-with-dexamethasone-dexamethasone-carfilzomib-dexamethasone-da\/#breadcrumbitem"}]}